We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
+3.39%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$661M
AUM Growth
-$473M
Cap. Flow
-$486M
Cap. Flow %
-73.58%
Top 10 Hldgs %
6.77%
Holding
1,175
New
248
Increased
83
Reduced
484
Closed
358

Top Buys

Rank Stock Value
1
CPNG icon
Coupang
CPNG
+$3.58M
2
AZO icon
AutoZone
AZO
+$3.03M
3
HWM icon
Howmet Aerospace
HWM
+$2.87M
4
ANSS
Ansys
ANSS
+$2.84M
5
IT icon
Gartner
IT
+$2.66M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$7.61M
2
GM icon
General Motors
GM
+$6.29M
3
BG icon
Bunge Global
BG
+$5.38M
4
QCOM icon
Qualcomm
QCOM
+$5M
5
USFD icon
US Foods
USFD
+$4.97M

Sector Composition

Rank Sector Weight
1 Technology 21.14%
2 Healthcare 20.5%
3 Financials 14.07%
4 Industrials 12.62%
5 Consumer Discretionary 11.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TNDM icon
351
Tandem Diabetes Care
TNDM
$1.27B
$658K 0.1%
+13,760
New +$754K
CERT icon
352
Certara
CERT
$1.26B
$648K 0.1%
+48,763
New +$901K
MTRN icon
353
Materion
MTRN
$3.94B
$648K 0.1%
8,098
-801
-9% -$66K
MANH icon
354
Manhattan Associates
MANH
$12.1B
$645K 0.1%
4,848
-925
-16% -$125K
CERS icon
355
Cerus
CERS
$575M
$642K 0.1%
178,423
-74,844
-30% -$358K
CIGI icon
356
Colliers International
CIGI
$5.17B
$642K 0.1%
+7,007
New +$817K
STEM icon
357
Stem
STEM
$44.3M
$640K 0.1%
+2,400
New +$614K
BHC icon
358
Bausch Health
BHC
$1.75B
$637K 0.1%
92,454
-181,796
-66% -$1.26M
MNDY icon
359
monday.com
MNDY
$3.82B
$634K 0.1%
5,592
+832
+17% +$98.5K
BKU icon
360
Bankunited
BKU
$3.33B
$631K 0.1%
18,459
-5,354
-22% -$200K
DNOW icon
361
DNOW Inc
DNOW
$2.44B
$631K 0.1%
62,833
-77,652
-55% -$839K
HCAT icon
362
Health Catalyst
HCAT
$160M
$630K 0.1%
64,982
+16,752
+35% +$222K
KOD icon
363
Kodiak Sciences
KOD
$2.5B
$630K 0.1%
81,343
-192,952
-70% -$1.87M
LAD icon
364
Lithia Motors
LAD
$9.75B
$629K 0.1%
2,934
+1,401
+91% +$366K
ITCI
365
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$628K 0.1%
+13,493
New +$705K
TBI
366
Trueblue
TBI
$227M
$626K 0.09%
32,820
-14,595
-31% -$295K
NSP icon
367
Insperity
NSP
$2.03B
$624K 0.09%
6,117
-2,902
-32% -$312K
UTZ icon
368
Utz Brands
UTZ
$1.24B
$621K 0.09%
+41,100
New +$666K
WEX icon
369
WEX
WEX
$6.42B
$621K 0.09%
4,890
-907
-16% -$143K
WOLF icon
370
Wolfspeed
WOLF
$1.04B
$620K 0.09%
6,000
-10,616
-64% -$1.02M
BYD icon
371
Boyd Gaming
BYD
$6.75B
$617K 0.09%
12,942
-2,876
-18% -$154K
WABC icon
372
Westamerica Bancorp
WABC
$1.39B
$617K 0.09%
11,805
-1,570
-12% -$89.5K
TW icon
373
Tradeweb Markets
TW
$23B
$615K 0.09%
+10,896
New +$742K
CWH icon
374
Camping World
CWH
$384M
$612K 0.09%
+24,188
New +$673K
DOX icon
375
Amdocs
DOX
$6.03B
$612K 0.09%
7,697
-3,609
-32% -$306K

Similar funds

PDT Partners's Q3 2022 Portfolio in Review

As of Q3 2022, PDT Partners held 1,175 positions worth $661M, down 42% from $1.13B the previous quarter. Its ten largest holdings account for 6.8% of the portfolio.

PDT Partners withdrew a net $486M in Q3 2022, closing 358 positions and reducing 484 holdings. Its most notable exit was Vertex Pharmaceuticals, an estimated $7.61M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

Against the trend, PDT Partners opened a new position in Coupang worth $3.45M.

  • PDT Partners's largest Q3 2022 buy was Coupang: 207,142 shares worth $3.45M.
  • PDT Partners added most to AutoZone in Q3 2022, an estimated $3.03M increase.
  • PDT Partners's biggest Q3 2022 reduction was General Motors, cutting an estimated $6.29M.
  • PDT Partners fully exited Vertex Pharmaceuticals in Q3 2022, selling an estimated $7.61M.
  • PDT Partners's ten largest holdings make up 6.8% of its $661M portfolio in Q3 2022.
  • PDT Partners opened 248 new positions and closed 358 in Q3 2022.
  • PDT Partners's portfolio value fell 42% quarter-over-quarter to $661M.

Based on PDT Partners's 13F filing for Q3 2022, filed 14 Nov 2022.